Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma

Abstract Background Growing evidence has suggested that immune-related genes play crucial roles in the development and progression of hepatocellular carcinoma (HCC). Nevertheless, the utility of immune-related genes for evaluating the prognosis of HCC patients are still lacking. The study aimed to e...

Full description

Bibliographic Details
Main Authors: Zheng Wang, Jie Zhu, Yongjuan Liu, Changhong Liu, Wenqi Wang, Fengzhe Chen, Lixian Ma
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-020-02255-6
_version_ 1819054807505174528
author Zheng Wang
Jie Zhu
Yongjuan Liu
Changhong Liu
Wenqi Wang
Fengzhe Chen
Lixian Ma
author_facet Zheng Wang
Jie Zhu
Yongjuan Liu
Changhong Liu
Wenqi Wang
Fengzhe Chen
Lixian Ma
author_sort Zheng Wang
collection DOAJ
description Abstract Background Growing evidence has suggested that immune-related genes play crucial roles in the development and progression of hepatocellular carcinoma (HCC). Nevertheless, the utility of immune-related genes for evaluating the prognosis of HCC patients are still lacking. The study aimed to explore gene signatures and prognostic values of immune-related genes in HCC. Methods We comprehensively integrated gene expression data acquired from 374 HCC and 50 normal tissues in The Cancer Genome Atlas (TCGA). Differentially expressed genes (DEGs) analysis and univariate Cox regression analysis were performed to identify DEGs that related to overall survival. An immune prognostic model was constructed using the Lasso and multivariate Cox regression analyses. Furthermore, Cox regression analysis was applied to identify independent prognostic factors in HCC. The correlation analysis between immune-related signature and immune cells infiltration were also investigated. Finally, the signature was validated in an external independent dataset. Results A total of 329 differentially expressed immune‐related genes were detected. 64 immune‐related genes were identified to be markedly related to overall survival in HCC patients using univariate Cox regression analysis. Then we established a TF-mediated network for exploring the regulatory mechanisms of these genes. Lasso and multivariate Cox regression analyses were applied to construct the immune-based prognostic model, which consisted of nine immune‐related genes. Further analysis indicated that this immune-related prognostic model could be an independent prognostic indicator after adjusting to other clinical factors. The relationships between the risk score model and immune cell infiltration suggested that the nine-gene signature could reflect the status of tumor immune microenvironment. The prognostic value of this nine-gene prognostic model was further successfully validated in an independent database. Conclusions Together, our study screened potential prognostic immune-related genes and established a novel immune-based prognostic model of HCC, which not only provides new potential prognostic biomarkers and therapeutic targets, but also deepens our understanding of tumor immune microenvironment status and lays a theoretical foundation for immunotherapy.
first_indexed 2024-12-21T12:57:30Z
format Article
id doaj.art-39019402c0154560a0552279b5123eda
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-12-21T12:57:30Z
publishDate 2020-02-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-39019402c0154560a0552279b5123eda2022-12-21T19:03:18ZengBMCJournal of Translational Medicine1479-58762020-02-0118111610.1186/s12967-020-02255-6Development and validation of a novel immune-related prognostic model in hepatocellular carcinomaZheng Wang0Jie Zhu1Yongjuan Liu2Changhong Liu3Wenqi Wang4Fengzhe Chen5Lixian Ma6Department of Infectious Diseases, Qilu Hospital, Shandong UniversityDepartment of Infectious Diseases, Qilu Hospital, Shandong UniversityShandong Center for Disease Control and Prevention, Health Education InstituteDepartment of Gastroenterology, Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated With Shandong First Medical UniversityDepartment of Gastroenterology, Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated With Shandong First Medical UniversityDepartment of Infectious Diseases, Qilu Hospital, Shandong UniversityDepartment of Infectious Diseases, Qilu Hospital, Shandong UniversityAbstract Background Growing evidence has suggested that immune-related genes play crucial roles in the development and progression of hepatocellular carcinoma (HCC). Nevertheless, the utility of immune-related genes for evaluating the prognosis of HCC patients are still lacking. The study aimed to explore gene signatures and prognostic values of immune-related genes in HCC. Methods We comprehensively integrated gene expression data acquired from 374 HCC and 50 normal tissues in The Cancer Genome Atlas (TCGA). Differentially expressed genes (DEGs) analysis and univariate Cox regression analysis were performed to identify DEGs that related to overall survival. An immune prognostic model was constructed using the Lasso and multivariate Cox regression analyses. Furthermore, Cox regression analysis was applied to identify independent prognostic factors in HCC. The correlation analysis between immune-related signature and immune cells infiltration were also investigated. Finally, the signature was validated in an external independent dataset. Results A total of 329 differentially expressed immune‐related genes were detected. 64 immune‐related genes were identified to be markedly related to overall survival in HCC patients using univariate Cox regression analysis. Then we established a TF-mediated network for exploring the regulatory mechanisms of these genes. Lasso and multivariate Cox regression analyses were applied to construct the immune-based prognostic model, which consisted of nine immune‐related genes. Further analysis indicated that this immune-related prognostic model could be an independent prognostic indicator after adjusting to other clinical factors. The relationships between the risk score model and immune cell infiltration suggested that the nine-gene signature could reflect the status of tumor immune microenvironment. The prognostic value of this nine-gene prognostic model was further successfully validated in an independent database. Conclusions Together, our study screened potential prognostic immune-related genes and established a novel immune-based prognostic model of HCC, which not only provides new potential prognostic biomarkers and therapeutic targets, but also deepens our understanding of tumor immune microenvironment status and lays a theoretical foundation for immunotherapy.https://doi.org/10.1186/s12967-020-02255-6Hepatocellular carcinomaImmune related genePrognosisPrognostic signatureBioinformatics
spellingShingle Zheng Wang
Jie Zhu
Yongjuan Liu
Changhong Liu
Wenqi Wang
Fengzhe Chen
Lixian Ma
Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma
Journal of Translational Medicine
Hepatocellular carcinoma
Immune related gene
Prognosis
Prognostic signature
Bioinformatics
title Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma
title_full Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma
title_fullStr Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma
title_full_unstemmed Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma
title_short Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma
title_sort development and validation of a novel immune related prognostic model in hepatocellular carcinoma
topic Hepatocellular carcinoma
Immune related gene
Prognosis
Prognostic signature
Bioinformatics
url https://doi.org/10.1186/s12967-020-02255-6
work_keys_str_mv AT zhengwang developmentandvalidationofanovelimmunerelatedprognosticmodelinhepatocellularcarcinoma
AT jiezhu developmentandvalidationofanovelimmunerelatedprognosticmodelinhepatocellularcarcinoma
AT yongjuanliu developmentandvalidationofanovelimmunerelatedprognosticmodelinhepatocellularcarcinoma
AT changhongliu developmentandvalidationofanovelimmunerelatedprognosticmodelinhepatocellularcarcinoma
AT wenqiwang developmentandvalidationofanovelimmunerelatedprognosticmodelinhepatocellularcarcinoma
AT fengzhechen developmentandvalidationofanovelimmunerelatedprognosticmodelinhepatocellularcarcinoma
AT lixianma developmentandvalidationofanovelimmunerelatedprognosticmodelinhepatocellularcarcinoma